Proteomics reveal biomarkers for diagnosis, disease activity and long-term disability outcomes in multiple sclerosis

Proteomics reveal biomarkers for diagnosis, disease activity and long-term disability outcomes in multiple sclerosis

Abstract Sensitive and reliable protein biomarkers are needed to predict disease trajectory and personalize treatment strategies for multiple sclerosis (MS). Here, we use the highly sensitive proximity-extension assay combined with next-generation sequencing (Olink Explore) to quantify 1463 proteins...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính: Julia Åkesson, Sara Hojjati, Sandra Hellberg, Johanna Raffetseder, Mohsen Khademi, Robert Rynkowski, Ingrid Kockum, Claudio Altafini, Zelmina Lubovac-Pilav, Johan Mellergård, Maria C. Jenmalm, Fredrik Piehl, Tomas Olsson, Jan Ernerudh, Mika Gustafsson
Định dạng: Bài viết
Ngôn ngữ:English
Được phát hành: Nature Portfolio 2023-10-01
Loạt:Nature Communications
Truy cập trực tuyến:https://doi.org/10.1038/s41467-023-42682-9

Internet

https://doi.org/10.1038/s41467-023-42682-9

Những quyển sách tương tự